Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

With the FDA’s breakthrough designation, this cutting-edge technology is quickly advancing through the approval process, underscoring its potential to transform the lives of those living with ...

The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...

Neuralink, a company founded by Elon Musk in 2016, is working on brain chip interfaces aimed at addressing disabilities like ...